Qualigen Therapeutics, Inc.
Qualigen Therapeutics, Inc. (QLGN) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 12 transactions totaling $112.1K, demonstrating a bullish sentiment with $112.1K in net insider flow. The most recent transaction on Jun 22, 2022 involved a purchase of 30,000 shares valued at $17.1K.
QLGN Insider Activity Summary
Who Is Buying QLGN Stock?
No significant insider buying has been recorded for QLGN in the recent period.
Who Is Selling QLGN Stock?
No significant insider selling has been recorded for QLGN in the recent period.
Is Qualigen Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for QLGN is bullish with an Insider Alignment Score of 100/100 and a net flow of $112.1K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
QLGN Frequently Asked Questions
Understanding QLGN Insider Activity
Insider trading at Qualigen Therapeutics, Inc. (QLGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading QLGN stock, having executed 12 transactions in the past 90 days. The most active insider is Kurt H. Kruger (Executive), who has made 5 transactions totaling $42.4K.
Related Tools
Track Qualigen Therapeutics, Inc. Insider Activity
Get notified when executives and directors at QLGN file new Form 4 transactions